{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:35:33Z","timestamp":1773768933516,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>The raw incidence of cancer of the uterine cervix is Spain is 7,8 per 100.000 inhabitants (adjusted incidence is 5.6). The incidence of this tumor is still low, but a steady increase has been seen, probably related to increasing risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>To determine the frequency of infection by different types of human papillomavirus (HPV) in Papanicolau smears from women with and without cancer of the uterine cervix in Spain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and methods<\/jats:title>\n            <jats:p>A case-control study was performed in women with and without cervical cancer from Zaragoza, Spain. Pap smears from 600 cases (540 women with cervical intraepithelial neoplasms (CIN) and 60 with invasive cancer) and 1200 controls (women without those lesions) were tested by polymerase chain reaction (PCR) and typed by oligonucleotide microarray-based detection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>HPV was detected in 93.3% of all samples with invasive cancer versus 17.5% of controls. OR for invasive cancer was 55 (95% CI 21.5\u2013140,5). Statistically significant associations were also found for different grades of cervical dysplasia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The strong association found between HPV infection, specifically types 16 and 18 and cancer of the uterine cervix in Zaragoza, Spain, stresses the importance of ongoing efforts to institute a vaccine program with recently approved HPV vaccines in order to prevent cervical cancer in this population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-9378-3-8","type":"journal-article","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T06:13:31Z","timestamp":1212128011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Human papillomavirus (HPV) infection and intraepithelial neoplasia and invasive cancer of the uterine cervix: a case-control study in Zaragoza, Spain"],"prefix":"10.1186","volume":"3","author":[{"given":"Milagros","family":"Bernal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Burillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose I","family":"Mayordomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Moros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquina","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,29]]},"reference":[{"key":"40_CR1","volume-title":"IARC Scientific Publications","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer in Five Continents. IARC Scientific Publications. 2005, VIII:"},{"issue":"918","key":"40_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/pmj.78.918.225","volume":"78","author":"AM Jastreboff","year":"2002","unstructured":"Jastreboff AM, Cymet T: Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J. 2002, 78 (918): 225-228. 10.1136\/pmj.78.918.225.","journal-title":"Postgrad Med J"},{"key":"40_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0090-8258(02)00069-0","volume":"89","author":"CJ Kim","year":"2003","unstructured":"Kim CJ, Jeong JK, Park M, Park TS, Park TC, Namkoong SE, Park JS: HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol. 2003, 89: 210-7. 10.1016\/S0090-8258(02)00069-0.","journal-title":"Gynecol Oncol"},{"issue":"325","key":"40_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","volume":"14","author":"SK Kjaer","year":"2002","unstructured":"Kjaer SK, Brule van den AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJ: Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ. 2002, 14 (325): 572-10.1136\/bmj.325.7364.572.","journal-title":"BMJ"},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/sti.79.3.191","volume":"79","author":"R Tachezy","year":"2003","unstructured":"Tachezy R, Salakova M, Hamsikova E, Kanka J, Havrankova A, Vonka V: Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions. Sex Transm Infect. 2003, 79: 191-6. 10.1136\/sti.79.3.191.","journal-title":"Sex Transm Infect"},{"issue":"3","key":"40_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ijc.2910610306","volume":"61","author":"AO Olsen","year":"1995","unstructured":"Olsen AO, Gjoen K, Sauer T, Orstavik I, Naess O, Kierulf K, Sponland G, Magnus P: Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. Int J Cancer. 1995, 61 (3): 312-5. 10.1002\/ijc.2910610306.","journal-title":"Int J Cancer"},{"key":"40_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0029-7844(00)00948-0","volume":"96","author":"I Heard","year":"2000","unstructured":"Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G: Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol. 2000, 96: 403-9. 10.1016\/S0029-7844(00)00948-0.","journal-title":"Obstet Gynecol"},{"key":"40_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0090-8258(03)00320-2","volume":"90","author":"DM Hernandez-Hernandez","year":"2003","unstructured":"Hernandez-Hernandez DM, Ornelas-Bernal L, Guido-Jimenez M, Apresa-Garcia T, Alvarado-Cabrero I, Salcedo-Vargas M, Mohar-Betancourt A, Garcia-Carranca A: Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol. 2003, 90: 310-7. 10.1016\/S0090-8258(03)00320-2.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"40_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1054\/bjoc.2001.1926","volume":"85","author":"GD Zielinski","year":"2001","unstructured":"Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, Linden van der HC, Runsink AP, de Schipper FA, Meijer CJ: HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer. 2001, 85 (3): 398-404. 10.1054\/bjoc.2001.1926.","journal-title":"Br J Cancer"},{"issue":"1","key":"40_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejogrb.2004.11.025","volume":"121","author":"R Arora","year":"2005","unstructured":"Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC: Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Obstet Gynecol Reprod Biol. 2005, 121 (1): 104-9. 10.1016\/j.ejogrb.2004.11.025.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9222","key":"40_CR11","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(00)02402-8","volume":"355","author":"N Ylitalo","year":"2000","unstructured":"Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, Adami HO, Gyllensten UB, Melbye M: Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet. 2000, 355 (9222): 2194-8. 10.1016\/S0140-6736(00)02402-8.","journal-title":"Lancet"},{"key":"40_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ygyno.2003.10.004","volume":"92","author":"JE Levi","year":"2004","unstructured":"Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, Pannuti CS: Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol. 2004, 92: 225-31. 10.1016\/j.ygyno.2003.10.004.","journal-title":"Gynecol Oncol"},{"issue":"14","key":"40_CR13","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005, 97 (14): 1072-9.","journal-title":"J Natl Cancer Inst"},{"key":"40_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/jmv.20154","volume":"74","author":"ML Tornesello","year":"2004","unstructured":"Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM: Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol. 2004, 74: 117-26. 10.1002\/jmv.20154.","journal-title":"J Med Virol"},{"issue":"1","key":"40_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejogrb.2004.11.025","volume":"121","author":"R Arora","year":"2005","unstructured":"Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC: Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Obstet Gynecol Reprod Biol. 2005, 121 (1): 104-9. 10.1016\/j.ejogrb.2004.11.025.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ygyno.2004.05.011","volume":"94","author":"N Masumoto","year":"2004","unstructured":"Masumoto N, Fujii T, Ishikawa M, Mukai M, Ono A, Iwata T, Kubushiro K, Nozawa S: Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients. Gynecol Oncol. 2004, 94: 509-14. 10.1016\/j.ygyno.2004.05.011.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"40_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<799::AID-IJC5>3.0.CO;2-5","volume":"82","author":"A Ferrera","year":"1999","unstructured":"Ferrera A, Velema JP, Figueroa M, Bulnes R, Toro LA, Claros JM, De Barahona O, Melchers WJG: Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study. Int J Cancer. 1999, 82 (6): 799-803. 10.1002\/(SICI)1097-0215(19990909)82:6<799::AID-IJC5>3.0.CO;2-5.","journal-title":"Int J Cancer"},{"key":"40_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Meter JF: Epidemiological Classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-27. 10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"key":"40_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijgo.2005.06.004","volume":"90","author":"BK Prusty","year":"2005","unstructured":"Prusty BK, Kumar A, Arora R, Batra S, Das BC: Human papillomavirus (HPV) DNA detection in self-collected urine. Int J Gynaecol Obstet. 2005, 90: 223-7. 10.1016\/j.ijgo.2005.06.004.","journal-title":"Int J Gynaecol Obstet"},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/annonc\/mdh240","volume":"15","author":"C Dannecker","year":"2004","unstructured":"Dannecker C, Siebert U, Thaler CJ, Kiermeir D, Hepp H, Hillemanns P: Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann Oncol. 2004, 15: 863-9. 10.1093\/annonc\/mdh240.","journal-title":"Ann Oncol"},{"issue":"18","key":"40_CR21","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.287.18.2372","volume":"287","author":"JS Mandelblatt","year":"2002","unstructured":"Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K: Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 2002, 287 (18): 2372-81. 10.1001\/jama.287.18.2372.","journal-title":"JAMA"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-3-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:53:24Z","timestamp":1630454004000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-3-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-3-8","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,29]]},"assertion":[{"value":"14 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}